P1552: A PHASE 2, OPEN-LABEL STUDY TO ASSESS SAFETY, TOLERABILITY, AND CLINICAL EFFECT OF ANX005 IN PATIENTS WITH WARM AUTOIMMUNE HEMOLYTIC ANEMIA AND EVIDENCE OF COMPLEMENT ACTIVATION

Bibliographic Details
Main Authors:	U. Jaeger, C. Broome, R. Go, A. Patriarca, A. Roeth, Q. Chang, N. Weedin, P. Adams, E. Cahir-McFarland, H.-A. Kroon
Format:	Article
Language:	English
Published:	Wiley 2022-06-01
Series:	HemaSphere
Online Access:	http://journals.lww.com/10.1097/01.HS9.0000849064.31599.55

Internet